There have been several additional press articles over the past few days regarding the Pediatric Hematology-Oncology Department at Hadassah Hospital Ein Kerem. If you have been following this news, you know that Prof. Mickey Weintraub has resigned and left the hospital. Prof. Weintraub was a highly regarded HMO physician who headed the department. When parents have a child with cancer, they often become emotional when a doctor who is responsible for their child's care leaves the hospital.
Director General Prof. Zeev Rotstein reacted immediately and the newly appointed department director started his position last week. This past Friday, Prof. Rotstein and Prof. Yoram Weiss, Director of Hadassah Ein Kerem, were interviewed by Israel's Channel 2 TV station and a local Israel radio station to explain how the children are being taken care of.
Prof. Rotstein stated today:
"The Department of Pediatric Hematology-Oncology is working at 100% capacity. The new Director of the Department, Dr. Gal Goldstein, has already started working and is developing an outstanding team. Dr. Goldstein came to HMO from Sheba Hospital, where he had a stellar reputation as a leading and caring Pediatric Oncologist. There is still a threat that several additional staff will leave. If this happens, management will work very quickly to replace them. No child is in danger of not receiving all the treatment needed."
Some of the press articles have reported that the department is closing, which is untrue. We are disappointed that the reporters and editors, who have misrepresented the situation at HMO, have not taken the time to fact check their stories.
We take great pride in the quality of care that patients at Hadassah's hospitals receive. We hope that the affected families will be reassured by our commitment to maintaining this same high quality of treatment and personalized caregiving for which the Pediatric Hematology-Oncology Department at HMO is known. Dr. Goldstein's team is already building hope and confidence as they help families face the extreme challenges of treating children with cancer.
Please contact me if you have further questions or concerns.